Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...